Product Code: ETC6664310 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Plasma Protein Therapeutics Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Plasma Protein Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Plasma Protein Therapeutics Market - Industry Life Cycle |
3.4 Canada Plasma Protein Therapeutics Market - Porter's Five Forces |
3.5 Canada Plasma Protein Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Canada Plasma Protein Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Canada Plasma Protein Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring plasma protein therapeutics |
4.2.2 Growing demand for plasma protein therapies due to advancements in healthcare infrastructure |
4.2.3 Rising investments in research and development for innovative plasma protein products |
4.3 Market Restraints |
4.3.1 High cost associated with plasma protein therapies |
4.3.2 Stringent regulatory requirements for approval and manufacturing of plasma protein therapeutics |
4.3.3 Limited availability of plasma donors leading to supply shortages |
5 Canada Plasma Protein Therapeutics Market Trends |
6 Canada Plasma Protein Therapeutics Market, By Types |
6.1 Canada Plasma Protein Therapeutics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Canada Plasma Protein Therapeutics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Canada Plasma Protein Therapeutics Market Revenues & Volume, By Albumin, 2021- 2031F |
6.1.4 Canada Plasma Protein Therapeutics Market Revenues & Volume, By Immunoglobulin, 2021- 2031F |
6.1.5 Canada Plasma Protein Therapeutics Market Revenues & Volume, By Plasma-derived Factor VIII, 2021- 2031F |
6.1.6 Canada Plasma Protein Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Canada Plasma Protein Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Canada Plasma Protein Therapeutics Market Revenues & Volume, By Hemophilia, 2021- 2031F |
6.2.3 Canada Plasma Protein Therapeutics Market Revenues & Volume, By Primary Immunodeficiency Disorder (PIDD), 2021- 2031F |
6.2.4 Canada Plasma Protein Therapeutics Market Revenues & Volume, By Idiopathic Thrombocytopenic Purpura (ITP), 2021- 2031F |
6.2.5 Canada Plasma Protein Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Plasma Protein Therapeutics Market Import-Export Trade Statistics |
7.1 Canada Plasma Protein Therapeutics Market Export to Major Countries |
7.2 Canada Plasma Protein Therapeutics Market Imports from Major Countries |
8 Canada Plasma Protein Therapeutics Market Key Performance Indicators |
8.1 Patient access to plasma protein therapies |
8.2 Adoption rate of new plasma protein products in the market |
8.3 Research and development expenditure on plasma protein therapies |
8.4 Number of approved plasma protein therapeutic products in Canada |
8.5 Patient satisfaction and outcomes with plasma protein therapies |
9 Canada Plasma Protein Therapeutics Market - Opportunity Assessment |
9.1 Canada Plasma Protein Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Canada Plasma Protein Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Canada Plasma Protein Therapeutics Market - Competitive Landscape |
10.1 Canada Plasma Protein Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Canada Plasma Protein Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |